Page last updated: 2024-11-05

zaleplon and Sleep Disorders, Circadian Rhythm

zaleplon has been researched along with Sleep Disorders, Circadian Rhythm in 1 studies

zaleplon: an azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; a hypnotic with less marked effect on psychomotor functions compared to lorazepam
zaleplon : A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.

Sleep Disorders, Circadian Rhythm: Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel (e.g., JET LAG SYNDROME), shift work, or other causes.

Research Excerpts

ExcerptRelevanceReference
"To assess the efficacy of zaleplon 10 mg and zolpidem 10 mg administered during experimental middle-of-the-night awakenings in patients with sleep-maintenance insomnia using objective polysomnographic measures and to assess daytime residual sedation 4 to 7 hours after dosing using sleep-latency testing."2.72Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening. ( Corser, B; Doghramji, K; Fry, JM; James, S; Krystal, A; Mangano, RM; Zammit, GK, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zammit, GK1
Corser, B1
Doghramji, K1
Fry, JM1
James, S1
Krystal, A1
Mangano, RM1

Trials

1 trial available for zaleplon and Sleep Disorders, Circadian Rhythm

ArticleYear
Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2006, Oct-15, Volume: 2, Issue:4

    Topics: Acetamides; Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Administration Sc

2006